Study guide
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification
Key Takeaways Explain This Topic AI
The ASA Physical Status Classification categorizes baseline physiologic reserve and systemic disease severity rather than surgical risk: ASA 1 (healthy), ASA 2 (mild systemic disease without functional limitation), ASA 3 (severe systemic disease with functional limitation), ASA 4 (severe systemic disease that is a constant threat to life), ASA 5 (moribund patient not expected to survive 24 hours without surgery), and ASA 6 (brain-dead organ donor).
The emergency modifier 'E' is appended when a delay in treatment significantly increases the threat to life or body part; 'E' can modify any classification (e.g., ASA 1E to ASA 5E).
Functional capacity measured in Metabolic Equivalents of Task (METs) is an independent predictor of perioperative cardiovascular risk: 1 MET = 3.5 mL O₂/kg/min (basal resting metabolic rate); ≥4 METs (climbing a flight of stairs, walking 4 mph / 6.4 km/h) signifies adequate reserve, whereas >10 METs indicates excellent functional capacity.
Preoperative airway assessment requires a multi-modal evaluation synthesizing Mallampati score (Class I–IV), thyromental distance (<6 cm predicts difficult laryngoscopy), inter-incisor opening (<3 cm), upper lip bite test (Class I–III), and cervical spine mobility (<35° extension).
A focused organ system review establishes baseline neurologic, cardiopulmonary, renal, hepatic, and endocrine functional reserves to anticipate intraoperative hemodynamic instability and guide anesthetic technique.
Last updated: August 2026
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification
The preoperative evaluation is the clinical cornerstone of anesthetic practice. Its primary objectives are to identify patient-specific comorbidities, determine physiological reserve, optimize chronic medical conditions, formulate an individualized anesthetic plan (general, neuraxial, peripheral nerve block, or monitored anesthesia care), and obtain informed consent. A structured preoperative assessment significantly decreases perioperative morbidity, mortality, and day-of-surgery case cancellations.
1. Components of the Comprehensive Preoperative Evaluation
An effective anesthetic assessment integrates the patient's medical history, prior anesthetic experiences, current pharmacotherapy, targeted physical examination, and selective diagnostic testing. +-------------------------------------------------------------------------+
- | COMPONENTS OF THE PREOPERATIVE EVALUATION |
- +-------------------+-----------------------------+-----------------------+
- | History & Review | Airway & Physical Exam | Risk Stratification |
- | - Medical/Surg Hx | - Airway classification | - ASA PS Class (1-6E) |
- | - Anesthetic Hx | - Cardiopulmonary exam | - METs functional cap |
- | - Allergies/Meds | - Baseline neurological | - Organ reserve |
- | - NPO & Habits | - Vascular access sites | - Plan formulation |
- +-------------------+-----------------------------+-----------------------+
- Essential Historical Elements
Personal and Familial Anesthetic History:
Malignant Hyperthermia (MH): Personal or family history of unexplained perioperative cardiac arrest, rhabdomyolysis, hyperpyrexia, or masseter spasm (autosomal dominant RYR1 or CACNA1S receptor mutations).
Pseudocholinesterase (Butyrylcholinesterase) Deficiency: History of prolonged apnea following succinylcholine or mivacurium administration.
Difficult Airway History: Prior failed intubation, tracheostomy, emergency cricothyroidotomy, or dental trauma.
Postoperative Nausea and Vomiting (PONV): Identification of Apfel risk factors (female gender, non-smoker, history of PONV/motion sickness, anticipated postoperative opioid use).
Delayed Emergence: History of prolonged recovery due to metabolic, pharmacodynamic, or central nervous system dysfunction.
Allergies vs. Adverse Drug Reactions:
Differentiate true IgE-mediated anaphylaxis (bronchospasm, angioedema, urticaria, profound cardiovascular collapse) from non-allergic adverse effects (e.g., nausea from codeine, histamine release from rapid morphine/atracurium administration, muscle fasciculations/myalgia from succinylcholine).
Document specific cross-reactivities: e.g., egg or soy anaphylaxis with propofol (rare, as propofol utilizes refined egg lecithin and soybean oil, but caution warranted in severe anaphylaxis), and amide vs. ester local anesthetic allergic mechanisms (esters metabolize to para-aminobenzoic acid [PABA], which is highly allergenic; amides rarely cause true allergy, often related to the preservative methylparaben).
Substance Use & Lifestyle Factors:
Tobacco: Number of pack-years, timing of last cigarette, presence of chronic bronchitis or emphysema.
Alcohol: Frequency and quantity; risk of acute intoxication (decreased anesthetic requirements) vs. chronic heavy use (upregulated CYP2E1 enzymes, increased anesthetic requirements, alcohol withdrawal syndrome / delirium tremens 48–72 hours postoperatively).
Recreational Drugs: Cocaine and amphetamines (acute intoxication causes massive sympathomimetic storm with risk of arrhythmias, ischemia, and hyperthermia; chronic abuse causes catecholamine depletion leading to severe refractory intraoperative hypotension).
NPO Status and Aspiration Risk Assessment:
Strict verification of the time and nature of the last oral intake (liquids, solids, fat content).
2. ASA Physical Status Classification System
The American Society of Anesthesiologists (ASA) Physical Status Classification System was originally introduced in 1941 to assess physical fitness and collect statistical data. It categorizes baseline physiologic reserve and systemic comorbidity severity. Crucial NCE Concept: The ASA PS score does not measure operative or surgical risk; rather, it reflects the patient's baseline physiological state at the time of assessment.
ASA Physical Status Definitions & Clinical Benchmarks
ASA Class Official ASA Definition Adult Clinical Examples Obstetric / Pediatric Examples
ASA 1 A normal healthy patient Non-smoking, no or minimal alcohol use, excellent exercise tolerance, no chronic medications Healthy pediatric patient; non-pregnant adult
ASA 2 A patient with mild systemic disease without substantive functional limitations Current social cigarette smoker; social alcohol drinker; well-controlled HTN; well-controlled DM (no end-organ damage); mild asthma/COPD; BMI 30 − 39.9 kg/m 2 30 - 39.9\text{ kg/m}^2 30 − 39.9 kg/m 2 Normal, uncomplicated pregnancy; term infant without congenital defects
ASA 3 A patient with severe systemic disease that results in substantive functional limitation ; one or more moderate-to-severe diseases Poorly controlled HTN or DM; symptomatic COPD; morbid obesity (BMI ≥ 40 kg/m 2 \ge 40\text{ kg/m}^2 ≥ 40 kg/m 2 ); active hepatitis; alcohol dependence/abuse; implanted pacemaker; moderate reduction in ejection fraction ( E F 35 − 49 % EF\ 35-49\% EF 35 − 49% ); ESRD on scheduled chronic dialysis; history ( > 3 months >3\text{ months} > 3 months ) of MI, CVA, TIA, or coronary stents Preeclampsia without severe features; gestational diabetes poorly controlled; preterm infant < 37 weeks <37\text{ weeks} < 37 weeks
ASA 4 A patient with severe systemic disease that is a constant threat to life Recent ( < 3 months <3\text{ months} < 3 months ) MI, CVA, or TIA; ongoing myocardial ischemia or severe valve dysfunction; severe reduction in ejection fraction ( E F < 30 % EF < 30\% EF < 30% ); sepsis; shock; DIC; acute respiratory distress syndrome (ARDS); ESRD not undergoing scheduled dialysis Preeclampsia with severe features; peripartum cardiomyopathy with severe decompensation
ASA 5 A moribund patient who is not expected to survive without the operation Ruptured abdominal or thoracic aortic aneurysm; massive polytrauma with hemorrhagic shock; intracranial hemorrhage with midline shift and herniation; ischemic bowel with multiorgan failure Uterine rupture with exsanguinating hemorrhage and profound shock
ASA 6 A declared brain-dead patient whose organs are being removed for donor purposes Certified brain death undergoing organ procurement Certified brain-dead pediatric or adult donor
'E' Modifier Emergency procedure: Delay in surgical treatment would significantly increase the threat to life or body part Appended to any class (e.g., ASA 1E for a healthy patient with acute appendicitis; ASA 3E for an end-stage diabetic with acute strangulated hernia) Emergent stat cesarean delivery for acute fetal bradycardia in a healthy mother (ASA 2E)
NCE Exam Trap — ASA Classification of Pregnancy & Morbid Obesity:
Pregnancy: A normal, completely healthy pregnant woman presenting for elective cesarean delivery is classified as ASA 2 (not ASA 1) due to the profound, altered physiological state of pregnancy (increased blood volume, hypercoagulability, reduced FRC, elevated cardiac output).
Obesity: A BMI of 30.0 − 39.9 kg/m 2 30.0 - 39.9\text{ kg/m}^2 30.0 − 39.9 kg/m 2 is ASA 2 ; a BMI ≥ 40 kg/m 2 \ge 40\text{ kg/m}^2 ≥ 40 kg/m 2 is ASA 3 .
Timeframe for Vascular Events: An MI or CVA occurring < 3 months <3\text{ months} < 3 months prior is ASA 4 ; an MI or CVA occurring > 3 months >3\text{ months} > 3 months prior with stable recovery is ASA 3 .
3. Functional Capacity & Metabolic Equivalents of Task (METs)
Functional capacity is a powerful, independent predictor of perioperative cardiovascular events and all-cause mortality. It is quantified using Metabolic Equivalents of Task (METs) .
Metabolic Equivalent Fundamentals 1 MET = 3.5 mL O 2 / kg/min \text{1 MET} = 3.5\text{ mL } O_2/\text{kg/min} 1 MET = 3.5 mL O 2 / kg/min
This represents the basal resting oxygen consumption of a 70-kg, 40-year-old male in the resting, seated position. +-------------------------------------------------------------------------+
- | FUNCTIONAL CAPACITY SPECTRUM (METs) |
- +--------------------+----------------------------+-----------------------+
- | Poor (<4 METs) | Moderate/Good (4-10 METs) | Excellent (>10 METs) |
- | - Eating, dressing | - Climbing 1-2 flights | - Strenuous sports |
- | - Walking indoors | - Walking 4 mph (6.4 km/h) | - Swimming laps |
- | - Cannot climb 1 fl| - Scrubbing floors, golf | - Singles tennis, run |
- +--------------------+----------------------------+-----------------------+
- Clinical Tiers of Functional Capacity
MET Tier Functional Level Clinical Activities & Benchmarks Perioperative Significance
< 4 METs < 4\text{ METs} < 4 METs Poor Self-care (eating, dressing, showering); walking 1–2 blocks on level ground at 2–3 mph ( 3.2 − 4.8 km/h 3.2-4.8\text{ km/h} 3.2 − 4.8 km/h ); light housework (dusting, washing dishes); inability to climb a flight of stairs without stopping High risk of perioperative myocardial ischemia, heart failure, and death; warrants further cardiac testing if high-risk surgery is planned
4 − 10 METs 4 - 10\text{ METs} 4 − 10 METs Moderate to Good Climbing 1–2 flights of stairs without stopping; walking up a hill; walking on level ground at 4 mph ( 6.4 km/h 6.4\text{ km/h} 6.4 km/h ); running a short distance; heavy housework (scrubbing floors, moving heavy furniture); recreational bowling or golfing without a cart Indicates sufficient cardiopulmonary reserve to tolerate most noncardiac surgical stresses without invasive cardiac testing
> 10 METs > 10\text{ METs} > 10 METs Excellent Participating in strenuous athletics (swimming, singles tennis, soccer, basketball, cross-country skiing, running/jogging > 5 mph >5\text{ mph} > 5 mph ) Extremely low risk of perioperative cardiac complications
ACC/AHA Key Decision Point: If an asymptomatic patient with stable cardiovascular disease has functional capacity of ≥ 4 METs \ge 4\text{ METs} ≥ 4 METs , they can safely proceed to elective noncardiac surgery without further noninvasive cardiac stress testing, regardless of surgical invasiveness.
4. Focused Preoperative Airway Physical Examination
A thorough airway examination identifies anatomic features associated with difficult mask ventilation, difficult supraglottic airway (SGA) placement, difficult direct/video laryngoscopy, and difficult surgical cricothyroidotomy. MALLAMPATI CLASSIFICATION (Sitting, Mouth Open, Tongue Protruded, NO Phonation)
- Class I Class II Class III Class IV
- +---------------+ +---------------+ +---------------+ +---------------+
- | Soft Palate | | Soft Palate | | Soft Palate | | |
- | Fauces | | Fauces | | Base of | | Hard Palate |
- | Uvula | | Portion of | | Uvula | | Only |
- | Tonsillar | | Uvula | | (NO Uvula | | |
- | Pillars | | | | Tip) | | |
- +---------------+ +---------------+ +---------------+ +---------------+
- Airway Risk Predictors
Modified Mallampati Score: Evaluated with patient seated upright, head in neutral position, mouth opened maximally, and tongue protruded without phonation :
Class I: Soft palate, fauces, uvula, and anterior/posterior tonsillar pillars fully visible.
Class II: Soft palate, fauces, and uvula visible (pillars masked by tongue base).
Class III: Soft palate and base of uvula visible.
Class IV: Hard palate only visible (soft palate completely hidden).
Thyromental Distance (TMD): Measured from the thyroid notch to the inside tip of the mandibular mentum with the neck fully extended. A distance < 6.0 cm <6.0\text{ cm} < 6.0 cm (or < 3 <3 < 3 fingerbreadths) indicates an acute anterior angle and poor mandibular space to displace the tongue during direct laryngoscopy.
Inter-Incisor Gap (Mouth Opening): Measured between the incisor teeth. An opening < 3.0 cm <3.0\text{ cm} < 3.0 cm ( < 2 <2 < 2 fingerbreadths) impedes insertion of standard laryngoscope blades and SGA devices.
Upper Lip Bite Test (ULBT / Mandibular Protrusion): Evaluates mandibular mobility:
Class I: Lower incisors can bite the upper lip above the vermilion border.
Class II: Lower incisors bite the upper lip below the vermilion border.
Class III: Lower incisors cannot reach the upper lip (associated with difficult laryngoscopy).
Neck Mobility: Normal cervical extension from neutral to full extension is ≥ 35 ∘ \ge 35^\circ ≥ 3 5 ∘ . Atlanto-occipital joint rigidity (e.g., severe osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, cervical spine fusion) prevents optimal "sniffing position" alignment (cervical flexion with atlanto-occipital extension).
5. Systematic Organ System Review
System Focus Areas High-Yield Preoperative Flags
Cardiovascular Ischemic disease, valvular stenosis/regurgitation, heart failure, arrhythmias, hypertension Angina stability, orthopnea, paroxysmal nocturnal dyspnea (PND), lower extremity edema, presence of S3 gallop or systolic ejection murmurs
Pulmonary Asthma, COPD, OSA, interstitial lung disease, recent URI Baseline wheezing, home oxygen requirements, exercise tolerance, nocturnal snoring/apneic spells, cough with purulent sputum within past 4 weeks
Renal Acute kidney injury (AKI), chronic kidney disease (CKD), hemodialysis Baseline serum creatinine/BUN, baseline potassium, dialysis schedule (dialyze within 24 hours prior to surgery; verify dry weight and post-dialysis potassium)
Hepatic Cirrhosis, portal hypertension, viral hepatitis Ascites, jaundice, encephalopathy, coagulation factor deficiencies (elevated PT/INR), platelet sequestration from splenomegaly
Endocrine Diabetes mellitus, thyroid disease, adrenal insufficiency Glycemic control (HbA1c), signs of autonomic neuropathy (gastroparesis, resting tachycardia, orthostatic hypotension), chronic steroid use requiring stress dosing
Neurologic Stroke/TIA, seizure disorder, neuromuscular disorders Baseline motor/sensory deficits (document prior to regional blocks), ICP elevation signs, safety of succinylcholine in denervation/myopathy